SUNSTAR HEALTHCARE INC
NT 10-K, 1999-03-31
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: V ONE CORP/ DE, 10-K, 1999-03-31
Next: ELAMEX SA DE CV, 10-K405, 1999-03-31




                             UNITED STATES                    OMB APPROVAL
                  SECURITIES AND EXCHANGE COMMISSION   -------------------------
                       Washington, D. C. 20549         OMB Number:     3235-0058
                                                       Expires:     May 31, 1997
                                                       Estimated average burden
                                                       hours per response...2.50
                              FORM 12b-25

                                                           SEC FILE NUMBER
                                                               1-14382

                        NOTIFICATION OF LATE FILING 
                                                             CUSIP NUMBER
                                                             867939 10 0

(Check One):[X]Form 10-KSB[ ]Form 20-F [ ]Form 11-K [ ]Form 10-QSB [ ]Form N-SAR

                   For Period Ended:_______________________  
                   [X] Transition Report on Form 10-K
                   [ ] Transition Report on Form 20-F
                   [ ] Transition Report on Form 11-K
                   [ ] Transition Report on Form 10-Q
                   [ ] Transition Report on Form N-SAR
                   For the Transition Period Ended:       December 31, 1998
                                                    ----------------------------


  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
           Nothing in this form shall be construed to imply that the
           Commission has verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates: 

- --------------------------------------------------------------------------------
PART I -- REGISTRANT  INFORMATION
SunStar Healthcare, Inc. 
- --------------------------------------------------------------------------------
Full Name of Registrant

- --------------------------------------------------------------------------------
Former Name if Applicable

      300 International Parkway, Suite 230
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

       Heathrow, Florida  32746
- --------------------------------------------------------------------------------
City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

           (a) The reasons  described in  reasonable  detail in Part III of this
         form could not be eliminated without unreasonable effort or expense;
           (b) The subject annual report,  semi-annual report, transition report
         on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion  thereof,  will
         be  filed  on or  before  the  fifteenth  calendar  day  following  the
[X]      prescribed  due date;  or the subject  quarterly  report or  transition
         report on Form 10-Q, or portion thereof, will be filed on or before the
         fifth calendar day following the prescribed due date; and
           (c) The  accountant's  statement  or other  exhibit  required by Rule
         12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable  detail the reasons why Forms 10-K,  20-F, 11-K, 10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. SEE ATTACHMENT A
                                                    
                                                 (Attach Extra Sheets if Needed)
                                                                 SEC 1344 (6/94)
<PAGE>

PART IV -- OTHER INFORMATION
(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification
           Jack W. Shields                 407                  304-1415
     ----------------------------    -----------------   -----------------------
               (Name)                   (Area Code)         (Telephone Number)


(2)  Have all other periodic  reports  required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter  period that the
     registrant was required to file such  report(s)  been filed?  If answer  is
     no, identify report(s).                                   [ ] Yes    [X] No
     Form   8-K   dated    April   20,   1998   was   filed   March   17,   1999
     ---------------------------------------------------------------------------
  

(3)  Is it anticipated that any significant change in results of operations from
     the corresponding  period for the last fiscal year will be reflected by the
     earnings  statements  to be  included  in the  subject  report  or  portion
     thereof?                                                  [ ] Yes    [X] No

     If so, attach an explanation of the anticipated  change,  both  narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of results cannot be made.

- --------------------------------------------------------------------------------

                            SunStar Healthcare, Inc.
                  (Name of Registrant as Specified in Charter)
                ------------------------------------------------
has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date   March 30, 1999              By   /s/ Jack W. Shields
- ---------------------------           ------------------------------------------
                                        Jack W. Shields, Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly  authorized  representative.  The name and title of the person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


                                    ATTENTION
            Intentional misstatements or omissions of fact constitute
               Federal Criminal Violations (See 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

1.   This form is  required by Rule  12b-25 (17 CFR  240.12b-25)  of the General
     Rules and Regulations under the Securities Exchange Act of 1934.

2.   One signed  original and four conformed  copies of this form and amendments
     thereto  must be  completed  and filed  with the  Securities  and  Exchange
     Commission,  Washington,  D.C.  20549,  in accordance  with Rule 0-3 of the
     General Rules and Regulations  under the Act. The information  contained in
     or filed  with  the form  will be made a matter  of  public  record  in the
     Commission files.

3.   A manually  signed copy of the form and  amendments  thereto shall be filed
     with each national  securities exchange on which any class of securities of
     the registrant is registered.

4.   Amendments to the notifications  must also be filed on form 12b-25 but need
     not restate information that has been correctly  furnished.  The form shall
     be clearly identified as an amended notification.

5.   Electronic Filers.  This form shall not be used by electronic filers unable
     to timely  file a report  solely  due to  electronic  difficulties.  Filers
     unable  to  submit  a  report  within  the time  period  prescribed  due to
     difficulties  in  electronic  filing  should comply with either Rule 201 or
     Rule 202 of Regulation  S-T  (ss.232.201  or ss.232.202 of this chapter) or
     apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation
     S-T (ss.232.13(b) of this chapter).

<PAGE>


                                  ATTACHMENT A

PART III - NARRATIVE


Completion  of the  Registrant's  Transition  Report on Form 10-KSB for the five
months  ended  December  31, 1998 has been  delayed due to delays in  finalizing
accounting  relating to the Registrant's  change in fiscal year end from July 31
to December 31, effective December 31, 1998.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission